Source comparison
Ipamorelin Protocol Comparison
Two-dose daily 200–300mcg upon waking, 200–300mcg before bed Morning nadir, pre-sleep surge Moderate (2–3× baseline) Simplest adherence; misses exercise-induced amplification Three-dose daily 200–300mcg upon waking, 200–300mcg pre-workout, 200–300mcg before be
This comparison does not assign a generated winner or score.
- Two-dose daily
- 200–300mcg upon waking, 200–300mcg before bed
- Morning nadir, pre-sleep surge
- Moderate (2–3× baseline)
- Simplest adherence; misses exercise-induced amplification
- Three-dose daily
- 200–300mcg upon waking, 200–300mcg pre-workout, 200–300mcg before bed
- Morning, exercise, pre-sleep
- High (3–5× baseline)
- Maximum GH amplification; requires consistent training schedule
- Pulsed weekly (5 days on, 2 off)
- 300mcg 2–3× daily for 5 days, none for 2 days
- All natural windows during active days
- Sustained without desensitization
- Prevents receptor downregulation over 8+ week cycles
- Stacked with CJC-1295
- 200mcg Ipamorelin + 100mcg CJC-1295 (no DAC) per injection
- Synergistic GHRH + ghrelin pathway activation
- Very high (5–8× baseline)
- CJC extends pulse duration; Ipamorelin increases amplitude. Combined effect multiplicative